# What is refeeding syndrome and how can it be prevented?

Canonical page: https://clinicsjo.com/en/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha
Language: en
Category: nutrition
Publisher: ClinicsJo
Published: 2026-09-13T17:52:53.566Z
Content updated: 2026-09-13T17:52:53.566Z
Translation (ar): https://clinicsjo.com/ar/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha

Refeeding syndrome is a severe metabolic disorder that can occur when starting nutritional support (oral, enteral, or parenteral) for individuals who have suffered from severe malnutrition or prolonged fasting [\[3\]](<https://clinicsjo.com/en/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha#source-S3>). This syndrome is characterized by a severe decrease in blood electrolyte levels such as phosphate, potassium, and magnesium, which may lead to serious complications affecting the heart and respiratory system [\[4\]](<https://clinicsjo.com/en/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha#source-S4>).

## Who is at the highest risk for refeeding syndrome?

Certain conditions are classified as high risk for developing refeeding syndrome if specific criteria are met. A person is considered high risk if they meet one or more of the following: a body mass index (BMI) less than 16 kg/m², unintentional weight loss greater than 15% within 3 to 6 months, or little to no food intake for more than 10 days [\[3\]](<https://clinicsjo.com/en/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha#source-S3>). A person is also considered high risk if they meet two or more of the following criteria: a BMI less than 18.5 kg/m², unintentional weight loss greater than 10% within 3 to 6 months, little to no food intake for more than 5 days, or a history of alcohol abuse or use of specific medications such as insulin, chemotherapy, antacids, or diuretics [\[3\]](<https://clinicsjo.com/en/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha#source-S3>). People suffering from low white blood cell counts or certain medical conditions such as liver disease and pneumonia are also at risk [\[4\]](<https://clinicsjo.com/en/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha#source-S4>).

## How is refeeding syndrome prevented?

Prevention relies on the gradual and cautious introduction of nutritional support, with close monitoring of the patient. For people at high risk, nutritional support should be started at a maximum of 10 kcal/kg of body weight per day, with levels increased slowly over 4 to 7 days to reach full requirements [\[3\]](<https://clinicsjo.com/en/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha#source-S3>). In very severe cases (such as a BMI less than 14 kg/m² or no food intake for more than 15 days), nutritional support may start at 5 kcal/kg per day, with continuous monitoring of heart rhythm [\[3\]](<https://clinicsjo.com/en/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha#source-S3>).

Other preventive measures include:

- **Electrolyte replacement:** Potassium (about 2 to 4 mmol/kg/day), phosphate (about 0.3 to 0.6 mmol/kg/day), and magnesium (about 0.2 mmol/kg/day intravenously or 0.4 mmol/kg/day orally) supplements should be provided before and during feeding, unless blood levels are already elevated [\[3\]](<https://clinicsjo.com/en/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha#source-S3>). Dairy products like milk, cheese, and yogurt are good sources of phosphate [\[4\]](<https://clinicsjo.com/en/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha#source-S4>).

- **Vitamin supplementation:** It is recommended to administer thiamine (200 to 300 mg daily) and vitamin B complex (one or two tablets three times daily, or a full intravenous dose if necessary) before and during the first 10 days of feeding [\[3\]](<https://clinicsjo.com/en/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha#source-S3>). A balanced daily multivitamin is also recommended [\[4\]](<https://clinicsjo.com/en/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha#source-S4>).

- **Fluid monitoring:** Circulatory volume should be restored, and fluid balance and general clinical status should be monitored closely [\[3\]](<https://clinicsjo.com/en/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha#source-S3>).

## Medical follow-up and warning signs

Nutritional support should be provided under the supervision of a multidisciplinary healthcare team including doctors, dietitians, and specialized nurses [\[3\]](<https://clinicsjo.com/en/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha#source-S3>). The nutritional support plan should be reviewed regularly based on the patient's progress and clinical condition [\[3\]](<https://clinicsjo.com/en/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha#source-S3>). It is very important that patients and caregivers are fully aware of the treatment and its options [\[3\]](<https://clinicsjo.com/en/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha#source-S3>). For more information on nutritional support in general, you can visit [Nutritional support: When is it necessary and how is it safely provided? (Arabic)](<https://clinicsjo.com/ar/articles/nutritional-support-when-necessary-how-safely-provided>).

Attention should be paid to any signs that may indicate complications, such as cardiac arrhythmias, muscle weakness, difficulty breathing, or swelling. These symptoms require immediate medical evaluation, as they may indicate metabolic instability requiring adjustment of the feeding plan and urgent medical intervention [\[4\]](<https://clinicsjo.com/en/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha#source-S4>).

## Medical references

- [Recommendations | Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition | Guidance | NICE](<https://www.nice.org.uk/guidance/cg32/chapter/Recommendations>)

- [Refeeding Syndrome and Eating Disorders :: Lancashire and South Cumbria NHS Foundation Trust](<https://www.lscft.nhs.uk/patient-information-leaflets/refeeding-syndrome-and-eating-disorders>)

General health education; not a substitute for individualized clinical assessment.

Citation URL: https://clinicsjo.com/en/faq/ma-hi-mutazimat-i-adat-al-taghthiya-wa-kayfa-yumkin-al-wiqaya-minha#answer
